No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 58.1x · 10Y median 58.1x · 57th percentile · as of Oct 2, 2026
Annual revenue · last 4 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-02T20:05:16.776Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-02T20:05:16.776Z. Latest historical point 2026-08-12.
The latest delayed quote for Cerebras Systems Inc. (CBRS) stock was $166.43 as of Oct 2, 2026, 4:00 PM EDT, down 1.82% from the previous close.
Cerebras Systems Inc. is a leading innovator in artificial intelligence infrastructure.
Semiconductors · Sunnyvale, CA
Next Earnings Date
Nov 12, 2026
41 days away
EPS Estimate
-0.15
Revenue Est.
$214.70M
Last Quarter Results
EPS
$-0.05
vs Estimate
$-0.18
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CBRS | $39.54B | $166.43 | -1.82% | N/A | N/A | N/A | N/A |
| 2CRDO | $40.77B | $218.64 | +4.03% | +45.07% | N/A | N/A | vs CBRS |
| 3TTWO | $37.91B | $202.73 | -0.44% | -20.29% | +5.13% | +16.27% | vs CBRS |
| 4UI | $37.56B | $620.57 | +1.79% | -9.09% | +16.26% | +28.50% | vs CBRS |
| 5FLEX | $43.08B | $116.61 | +3.40% | +94.50% | +43.98% | +23.54% | vs CBRS |
| 6ROP | $35.76B | $354.32 | -2.28% | -26.56% | -3.51% | +7.76% | vs CBRS |
forward FY estimate
N/A
$209.87M
vs Estimate
$190.58M
Consensus Rating
Based on 11 analysts
Average Price Target
$291.64
+75.2% upside
Low
$209.00
Current
$166.43
High
$330.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.25 | $-0.15 | $-0.04 | 6 |
| Quarter ending Dec 2026 | $-0.41 | $-0.25 | $-0.06 | 6 |
| Quarter ending Mar 2027 | $-0.08 | $-0.08 | $-0.08 | 2 |
| Quarter ending Jun 2027 | $0.11 | $0.11 | $0.12 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.00 | $-0.52 | $-0.16 | 6 |
| FY 2027 | $1.00 | $1.24 | $1.50 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $214.19M | $214.70M | $215.22M | 5 |
| Quarter ending Dec 2026 | $274.05M | $274.41M | $274.75M | 5 |
| Quarter ending Mar 2027 | $398.07M | $402.57M | $423.69M | 4 |
| Quarter ending Jun 2027 | $562.08M | $568.43M | $598.26M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $885.00M | $885.31M | $885.62M | 7 |
| FY 2027 | $2.63B | $2.85B | $3.05B | 8 |
